Crohn s & Colitis 360
Source
ISSN 2631-827X
Source type: journal
Publisher: Oxford University Press
Alternate name CC360
Fully open access: Yes
In DOAJ: Yes
Article Processing Charge: $2,975
2yr mean citedness: 2.455
H-index: 20
I10-index: 62
Works count: 303
Citations count: 1,858
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
2022 · Quazim A. Alayo, Marc Fenster, et al. · Crohn s & Colitis 360
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
2020 · Peter Higgins, Siew C. Ng, et al. · Crohn s & Colitis 360
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
2023 · Remo Panaccione, Eric B. Collins, et al. · Crohn s & Colitis 360